Cardiac resynchronization therapy: "nonresponders" and "hyperresponders".
about
Contractile reserve assessed by dobutamine test identifies super-responders to cardiac resynchronization therapy.Temporal pattern of left ventricular structural and functional remodeling following reversal of volume overload heart failure.Reverse left ventricular remodeling is more likely in non ischemic cardiomyopathy patients upgraded to biventricular stimulation after chronic right ventricular pacing.Follow-up of patients with new cardiovascular implantable electronic devices: are experts' recommendations implemented in routine clinical practice?Assessing reverse remodeling in heart failure patients treated with cardiac resynchronization therapy and its impact on prognosis.Cellular and Molecular Aspects of Dyssynchrony and Resynchronization.Roles and indications for use of implantable defibrillator and resynchronization therapy in the prevention of sudden cardiac death in heart failure.Cardiac resynchronization therapy (CRT) device replacement considerations: upgrade or downgrade? A complex decision in the current clinical setting.Long-term outcome of patients with and without super-response to CRT-D.Hyper-response to cardiac resynchronization with permanent His bundle pacing: Is parahisian pacing sufficient?Close connection between improvement in left ventricular function by cardiac resynchronization therapy and the incidence of arrhythmias in cardiac resynchronization therapy-defibrillator patients.Patients with non-ischaemic dilated cardiomyopathy and hyper-responders to cardiac resynchronization therapy: characteristics and long-term evolution.Outcome of super-responders to cardiac resynchronization therapy defined by endpoint-derived parameters of left ventricular remodeling: a two-center retrospective study.A clinical phenotype of adverse response to biventricular pacing: a case series.True complete left bundle branch block morphology strongly predicts good response to cardiac resynchronization therapy.Normalization of left ventricular ejection fraction after cardiac resynchronization therapy also normalizes survival.Extraordinarily favorable left ventricular reverse remodeling through long-term cardiac resynchronization: super-response to cardiac resynchronization.Hyperresponders to cardiac resynchronization therapy: timing is everything… but size still matters!The incidence and outcomes of delayed response to cardiac resynchronization therapy.Clinical characteristics and predictors of super-response to cardiac resynchronization therapy: a combination of predictive factors.Predicting hyperresponse among pacemaker-dependent nonischemic cardiomyopathy patients upgraded to cardiac resynchronization.Predictors of super-response to cardiac resynchronization therapy: the significance of heart failure medication, pre-implant left ventricular geometry and high percentage of biventricular pacing.Not left ventricular lead position, but the extent of immediate asynchrony reduction predicts long-term response to cardiac resynchronization therapy
P2860
Q34247208-DCA8CDB9-A16C-459A-9391-A454D1BD4D0EQ35601668-72598CDE-8A1E-428C-8578-1A6DFDD315ADQ35692755-ECEFA653-2554-4457-B722-852C1085E85CQ36806574-E21F730F-A020-4EF4-ABF9-5ED582C47191Q38067777-ABC528B7-2337-4256-B8E7-2D5D1EE7A22BQ38644094-C51D60C4-4B2D-45EF-BAD3-F3F3C7FE9329Q38903885-E96160C3-3B19-4689-8724-E06B8C186A4EQ39052134-DA87081B-62EC-4A3F-9E6A-B1C2ECC90912Q41190106-2F758FA4-79E4-4401-A1E1-98B656EF1F8AQ41351208-760DD6C4-7049-4AF1-9945-4426FBF556A0Q43956436-E17CC771-68C2-440C-B178-1DEA2CE1AB6CQ44531360-4B9721FC-673B-44C8-A181-386BA2F202F8Q44618043-CEE83006-4664-4033-A20B-CCB8F5616B5FQ45410046-5233171F-CBF0-47DD-B881-FFB188DEC2B5Q45767028-CD70ADF1-0FD2-4109-91F4-9276ADEE6510Q45788170-A1FB0FE8-5E22-4D71-9BD2-0214827258A5Q46617109-FD38B6A6-C30D-4E0D-8531-30686564CD9CQ47387658-D85D7AD4-E72C-4E37-A8A6-075ED347A7D1Q48148952-91F6E556-52FD-4E29-AD0A-7577E1104174Q50632349-A4D5B871-76F5-4834-9B04-38EDB5C71AA2Q53906525-6BFFF098-FC2A-4F26-843D-526988338E63Q55359339-056FE5AE-0951-4D66-A8E7-30CF8A0FCF14Q56962767-0BA44DDD-4BEE-411C-916D-5D50E22EFBCC
P2860
Cardiac resynchronization therapy: "nonresponders" and "hyperresponders".
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Cardiac resynchronization therapy: "nonresponders" and "hyperresponders".
@en
Cardiac resynchronization therapy: "nonresponders" and "hyperresponders".
@nl
type
label
Cardiac resynchronization therapy: "nonresponders" and "hyperresponders".
@en
Cardiac resynchronization therapy: "nonresponders" and "hyperresponders".
@nl
prefLabel
Cardiac resynchronization therapy: "nonresponders" and "hyperresponders".
@en
Cardiac resynchronization therapy: "nonresponders" and "hyperresponders".
@nl
P2093
P1433
P1476
Cardiac resynchronization therapy: "nonresponders" and "hyperresponders".
@en
P2093
Jean-Jacques Blanc
Marjaneh Fatemi
Philippe Castellant
Valerie Bertault-Valls
Yves Etienne
P304
P356
10.1016/J.HRTHM.2007.09.023
P577
2007-10-02T00:00:00Z